Delivery Order SPE2DR25D2003-SPE2DR26FR04E
- Not listed
- The Defense Logistics Agency awarded a $4,290.06 delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of Kerendia 20 mg tablets (30-count packages). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of November 13, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Kerendia 20 mg tablets (30-count) with a ceiling value of $1,038.89. This competitively awarded, firm fixed-price delivery order is not set-aside and is scheduled for completion by December 11, 2025. AmerisourceBergen will fulfill this requirement from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a...
- The Defense Logistics Agency awarded a $2,337.94 delivery order to AmerisourceBergen Drug Corp for 30 tablets of Kerendia 10 mg on December 12, 2025, with an ultimate completion date of December 15, 2025. This firm fixed-price contract, which carries no set-aside designation, represents a competitively awarded delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The pharmaceutical product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,110.21 on December 12, 2025, for the supply of Kerendia 10 mg tablets (30-count units). This competitively awarded, firm fixed-price contract represents a non-set-aside procurement supporting federal medical supply needs. The ultimate completion date is December 15, 2025, with performance occurring at the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order is executed under...
- The Defense Logistics Agency awarded a $1,914.67 delivery order to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Kerendia 10 mg tablets (30-count). This is a firm fixed price, non-set-aside contract with an ultimate completion date of November 26, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement under AmerisourceBergen's existing contract vehicles with the...
- The Defense Logistics Agency awarded a delivery order valued at $5,658.96 to AmerisourceBergen Drug Corp for the supply of Kerendia 10 mg tablets (30-count units) on December 2, 2025, with completion scheduled for December 3, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award selection. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs,...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Kerendia 20 mg tablets (30-count units) under a firm fixed-price arrangement. The contract, issued on December 17, 2025, has a ceiling value of $6,469.15 and an ultimate completion date of December 18, 2025. This non-competitive award represents a child contract action executed under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $46,258.28 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Kerendia 10 mg tablets (30-count units). The contract, designated as a non-set-aside competitive award, is scheduled for completion by December 5, 2025, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,123.04 to AmerisourceBergen Drug Corp for Kerendia 10 mg tablets (90-count supply) on December 12, 2025, with an ultimate completion date of December 15, 2025. This firm fixed-price delivery order is non-set-aside and represents a child contract under AmerisourceBergen's broader indefinite delivery vehicle with the DLA. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Kerendia 10 mg tablets in a 30-count package with a ceiling value of $14,581.71 under firm fixed pricing. This non-set-aside delivery order, due for completion by December 2, 2025, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a critical pharmaceutical supplier...
- SPE2DR25D2003Indefinite Delivery Contract
- SPE2DR25D2003-SPE2DR26FR04EDelivery Order
The Defense Logistics Agency awarded a $84,028.25 delivery order to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of Kerendia 20 mg tablets (30-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of December 18, 2025, and performance to be executed from the contractor's Conshohocken, Pennsylvania facility. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement running through December 2026 that enables global pharmaceutical support for military healthcare operations. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor headquartered in Pennsylvania. The company maintains an extensive federal contract portfolio with the Defense Logistics Agency and its Medical Supply Chain, supplying a comprehensive range of pharmaceutical products including brand-name and generic medications, vaccines, and medical devices across multiple therapeutic domains. All of the company's reviewed contract awards have been competitively awarded with firm fixed pricing, demonstrating its capability to meet federal procurement requirements through open competition and serve defense healthcare customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $84.0k | 12/16/25 |